REPORT SCOPE
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This report provides an overview of the tissue engineering and regeneration industry. It describes existing products on the market and offers detailed analysis of the competitive environments, including new and potential markets for novel therapies and treatments. The study includes information about significant industry players, trends, and obstacles, and discusses factors affecting the development of new products, devices, and therapies.
REASONS FOR DOING THIS STUDY
Tissue engineering is a multidisciplinary study involving biology, medicine, and engineering to create products and devices that will improve or replace biological functions and organs. The first experiments in tissue engineering date back to the 1960s. More than a decade ago, the industry introduced the first FDA-approved, tissue-engineered commercial product—artificial skin substitute.
Although tissue engineering has enormous commercial potential, it seems that this market develops at a very slow pace. After the introduction of skin substitutes and cartilage regeneration products in the last decade or so, not much progress has been made in the industry. Moreover, some of the products have been discontinued. One of the main reasons for this slow development is the biological complexity of growing organs and tissue replacements. In addition, current technologies are not efficient enough to make these products cost-effective alternatives.
Overall, the tissue engineering market is a heterogeneous industry and can be divided into number of subsectors. Skin substitutes are a relatively developed segment, while tissue-engineered products for the nervous system comprise a sector that is still in a preliminary stage. Recent developments in regeneration research, especially stem cell research, give hope that new scientific breakthroughs will lead to innovative products.
In summary, this report will highlight the main segments of the tissue engineering and regeneration industry, its major market participants, and current and future market trends. The report will also highlight specific geographical regions that have individual market characteristics. Drivers and challenges in each sector of this industry will be discussed in detail, including forecasts for the next 5 years.
SCOPE AND FORMAT
This report is a current and important business tool for evaluating new, commercial opportunities in the tissue engineering market. The geographic scope of this study covers the U.S., Europe, and other parts of the world. The market is complex and consists of many sectors, each affected differently by scientific and technological developments. The report identifies the primary positive and negative factors in each sector and forecasts future trends, products, and therapies for each category.
METHODOLOGY AND INFORMATION SOURCES
The research methodology was more qualitative than quantitative in nature, and employed a triangulating approach, which strengthens validity. Initially, a comprehensive and exhaustive search of the literature on drug discovery and already marketed products was conducted. These secondary sources included drug discovery and science-related journals, textbooks, press releases, marketing literature, other product/promotional literature, annual reports, security analyst reports, and other publications. A patent search and analysis was also conducted.
In a second phase, a series of semi-structured interviews was conducted with company representatives, bench scientists, marketing representatives, and other personnel at biotech and pharmaceutical companies. Other resources included academic institutions and technology and consulting companies, which were a rich source of data. Subsequent analysis of the documents and interview notes was iterative.
INTENDED AUDIENCE
This report is intended for business development professionals, entrepreneurs, and other investment groups in order to fully understand and evaluate properly each segment in the tissue engineering and regeneration industry. It provides companies with new insights into competitors’ positions and discusses new opportunities otherwise overlooked or less known to the public.
ANALYST CREDENTIALS
Dr. Marianna Tcherpakov has more than 7 years of experience as a bench scientist specializing in the area of biochemistry, cell biology, and industrial assay development. She has contributed to a number of scientific publications and holds several patents. She has expertise as an assay development scientist and is familiar with different research field trends and probable future developments.
BCC ON-LINE SERVICES
BCC Research offers an online information retrieval service. Its home page, located at www.bccresearch.com, enables readers to:
- Examine the complete BCC Research catalog of market research reports and place direct orders
- Subscribe to any of BCC Research’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters.
- Register for its well-known conferences.
- Request additional information on any BCC research product.
- Take advantage of special offers.
DISCLAIMER
This publication provides informative material of a professional nature. It does not constitute managerial, legal, or accounting advice, nor should it serve as a corporate policy guide or an endorsement of any given product or company. This information is intended to be as accurate as possible at the time it was written and was undertaken on a best-effort basis. The views expressed are those of the author and do not make any warranty, express or implied, for the accuracy, completeness, or usefulness of the information, or for the interpretation of data or its use by others. Projections involve risks and uncertainties that include but are not limited to technical risks associated with technology development, government regulatory approvals, and access to capital. The author assumes no responsibility for any losses or damages that may result from one’s reliance on this material.
